Stock vs Stock Comparison

Elevance Health, Inc. vs Agilent Technologies, Inc.

A wins the Tale of the Tape 6–3.

ELV$391.27
A$137.40

🏆 Tale of the Tape

36
ELVA
2.8%Profitability (Net Margin)18.8%
16.7xValuation (P/E)27.3x
5.3%Efficiency (ROIC)11.8%
4/9Health (Piotroski F)5/9
2.8Safety (Altman Z)4.6
12.6%Growth (Rev YoY)6.7%
-0.67Risk (Sharpe 1Y)0.32
1.76xBalance Sheet (D/E)0.89x
3.52%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.248
252-Day Correlation
0.261
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricELVA
Market Cap$85.4B$38.2B
P/E Ratio16.7x27.3x
Forward P/E13.4x20.5x
P/B1.95x5.37x
Dividend Yield1.75%0.75%
Beta0.671.22

Quantitative Metrics

MetricELVA
DCF Fair Value$175.51$50.34
DCF Upside-44.5%-57.1%
Piotroski F4/95/9
Altman Z2.804.57
Beneish M-2.46
FCF Yield3.52%3.41%
Net Debt/EBITDA2.2x0.7x
ROIC5.3%11.8%
WACC6.8%12.1%
ROIC – WACC-1.5pp-0.3pp
Gross Margin52.4%
Net Margin2.8%18.8%
Rev Growth YoY12.6%6.7%
Sharpe (1Y)-0.670.32
Max Drawdown 3Y-50.4%
FCF Payout Ratio48%24%

ELV Price

Loading chart...

A Price

Loading chart...

ETF Exposure

ELV found in:

XHS2.42%
XLV1.61%
VHT1.32%
VFVA0.54%
MGV0.40%
VIG0.37%
VYM0.34%
VTV0.32%
SPYV0.30%
QUS0.29%
VONV0.25%
SCHV0.24%
IWD0.21%
RSP0.20%
SPY0.13%
IVV0.13%
ESGV0.13%
VOO0.13%
SPLG0.13%
SPTM0.12%
VONE0.12%
VTI0.12%
ITOT0.12%
SCHX0.11%
SCHB0.11%
ONEO0.10%
GWX0.09%
URTH0.09%
ACWI0.08%
VT0.07%
SPDW0.00%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ELV vs A: Head-to-Head Analysis

Elevance Health, Inc. (ELV) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ELV generates a return on invested capital (ROIC) of 5.3% compared to A's 11.8%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ELV and A is 0.248, indicating low correlation, making them an effective diversification pair in a portfolio context.

ELV appears in 31 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ELV or A?

Our quantitative analysis compares ELV and A across nine fundamental dimensions. A wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ELV and A correlated?

The 252-day correlation between ELV and A is 0.248. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.